Adjuvant breast cancer chemotherapy during late-trimester pregnancy: Not quite a standard of care

BMC Cancer

Volumn 7, Issue , 2007, Pages

  Epstein, Richard J ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT; TAXANE DERIVATIVE; TRASTUZUMAB;

ABORTION; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL PROTOCOL; CONGENITAL MALFORMATION; DELIVERY; DRUG SAFETY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATION PERIOD; HUMAN; INFERTILITY; PATIENT CARE; PATIENT DECISION MAKING; PATIENT SAFETY; PROGENY; RISK BENEFIT ANALYSIS; THERAPY DELAY; THIRD TRIMESTER PREGNANCY; WELLBEING; ADJUVANT CHEMOTHERAPY; BREAST TUMOR; CARCINOMA; DECISION TREE; DRUG EFFECT; EVALUATION; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; RISK ASSESSMENT; TIME;

ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; DECISION TREES; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, THIRD; RISK ASSESSMENT; TIME FACTORS;

EID: 34347230914     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-7-92     Document Type: Article

References (42)

1. Berry DL Theriault RL Holmes FA Parisi VM Booser DJ Singletary SE Buzdar AU Hortobagyi GN Management of breast cancer during pregnancy using a standardized protocol J Clin Oncol 1999 17 3 855-861 10071276
2. Loibl S von Minckwitz G Gwyn K Ellis P Blohmer JU Schlegelberger B Keller M Harder S Theriault RL Crivellari D Klingebiel T Louwen F Kaufmann M Breast carcinoma during pregnancy. International recommendations from an expert meeting Cancer 2006 106 2 237-246 10.1002/ cncr.21610 16342247
3. Woo JC Yu T Hurd TC Breast cancer in pregnancy: A literature review Arch Surg 2003 138 1 91-8; discussion 99 12511159
4. Ring AE Smith IE Jones A Shannon C Galani E Ellis PA Chemotherapy for breast cancer during pregnancy: An 18-year experience from five London teaching hospitals J Clin Oncol 2005 23 18 4192-4197 10.1200/ JCO.2005.03.038 15961766
5. Gwyn KM Theriault RL Breast cancer during pregnancy Curr Treat Options Oncol 2000 1 3 239-243 12057166
6. Bawle EV Conard JV Weiss L Adult and two children with fetal methotrexate syndrome Teratology 1998 57 2 51-55 10.1002/ (SICI)1096-9926(199802)57:2<51::AID-TERA2>3.0.CO;2-9 9562676
7. Paskulin GA Gazzola Zen PR de Camargo Pinto LL Rosa R Graziadio C Combined chemotherapy and teratogenicity Birth Defects Res A Clin Mol Teratol 2005 73 9 634-637 10.1002/bdra.20180 16104005
8. Watson WJ Herceptin (trastuzumab) therapy during pregnancy: Association with reversible anhydramnios Obstet Gynecol 2005 105 3 642-643 15738038
9. Cold S During M Ewertz M Knoop A Moller S Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG) Br J Cancer 2005 93 6 627-632 10.1038/sj.bjc.6602734 16136052
10. Lohrisch C Paltiel C Gelmon K Speers C Taylor S Barnett J Olivotto IA Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer J Clin Oncol 2006 24 30 4888-4894 10.1200/JCO.2005.01.6089 17015884
11. Buzdar AU Smith TL Powell KC Blumenschein GR Gehan EA Effect of timing of initiation of adjuvant chemotherapy on disease-free survival in breast cancer Breast Cancer Res Treat 1982 2 2 163-169 10.1007/ BF01806452 6897369
12. Shannon C Ashley S Smith IE Does timing of adjuvant chemotherapy for early breast cancer influence survival? J Clin Oncol 2003 21 20 3792-3797 10.1200/JCO.2003.01.073 14551298
13. Nettleton J Long J Kuban D Wu R Shaefffer J El-Mahdi A Breast cancer during pregnancy: Quantifying the risk of treatment delay Obstet Gynecol 1996 87 3 414-418 10.1016/0029-7844(95)00470-X 8598965
14. Giacalone PL Laffargue F Benos P Chemotherapy for breast carcinoma during pregnancy: A French national survey Cancer 1999 86 11 2266-2272 10.1002/(SICI)1097-0142(19991201)86:11<2266::AID-CNCR14>3.0.CO;2-7 10590367
15. Colleoni M Bonetti M Coates AS Castiglione-Gertsch M Gelber RD Price K Rudenstam CM Lindtner J Collins J Thurlimann B Holmberg S Veronesi A Marini G Goldhirsch A Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group J Clin Oncol 2000 18 3 584-590 10653873
16. Cole BF Gelber RD Gelber S Coates AS Goldhirsch A Polychemotherapy for early breast cancer: An overview of the randomised clinical trials with quality-adjusted survival analysis Lancet 2001 358 9278 277-286 10.1016/ S0140-6736(01)05483-6 11498214
17. Wittes RE Problems in the medical interpretation of overviews Stat Med 1987 6 3 269-280 10.1002/sim.4780060312 3616283
18. Verlinden I Gungor N Wouters K Janssens J Raus J Michiels L Parity-induced changes in global gene expression in the human mammary gland Eur J Cancer Prev 2005 14 2 129-137 10.1097/ 00008469-200504000-00008 15785316
19. Phillips KA Milne RL Friedlander ML Jenkins MA McCredie MR Giles GG Hopper JL Prognosis of premenopausal breast cancer and childbirth prior to diagnosis J Clin Oncol 2004 22 4 699-705 10.1200/JCO.2004.07.062 14966094
20. Rosenberg L Thalib L Adami HO Hall P Childbirth and breast cancer prognosis Int J Cancer 2004 111 5 772-776 10.1002/ijc.20323 15252849
21. Regan MM Gelber RD Predicting response to systemic treatments: Learning from the past to plan for the future Breast 2005 14 6 582-593 10.1016/ j.breast.2005.08.021 16199162
22. Ring AE Smith IE Ashley S Fulford LG Lakhani SR Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer Br J Cancer 2004 91 12 2012-2017 10.1038/sj.bjc.6602235 15558072
23. Manna Edel F Teixeira LC Alvarenga M Association between immunohistochemical expression of topoisomerase IIalpha, HER2 and hormone receptors and response to primary chemotherapy in breast cancer Tumori 2006 92 3 222-229 16869240
24. Colleoni M Viale G Zahrieh D Pruneri G Gentilini O Veronesi P Gelber RD Curigliano G Torrisi R Luini A Intra M Galimberti V Renne G Nole F Peruzzotti G Goldhirsch A Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: A study of preoperative treatment Clin Cancer Res 2004 10 19 6622-6628 10.1158/ 1078-0432.CCR-04-0380 15475452
25. Aebi S Special issues related to the adjuvant therapy in very young women Breast 2005 14 6 594-599 10.1016/j.breast.2005.08.011 16185868
26. Roche H Kerbrat P Bonneterre J Fargeot P Fumoleau P Monnier A Clavere P Goudier MJ Chollet P Guastalla JP Serin D Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal, one to three node-positive, and hormone-receptor positive, early breast cancer patients: 7-year follow-up results of French Adjuvant Study Group 06 randomised trial Ann Oncol 2006 17 8 1221-1227 10.1093/annonc/mdl107 16731539
27. Peccatori F Martinelli G Gentilini O Goldhirsch A Chemotherapy during pregnancy: What is really safe? Lancet Oncol 2004 5 7 398 10.1016/ S1470-2045(04)01506-2 15231245
28. Aviles A Niz J Long-term follow-up of children born to mothers with acute leukemia during pregnancy Med Pediatr Oncol 1988 16 1 3-6 10.1002/ mpo.2950160102 3340063
29. Aviles A Diaz-Maqueo JC Talavera A Guzman R Garcia EL Growth and development of children of mothers treated with chemotherapy during pregnancy: Current status of 43 children Am J Hematol 1991 36 4 243-248 10.1002/ajh.2830360404 1707227
30. Fanale MA Uyei AR Theriault RL Adam K Thompson RA Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy Clin Breast Cancer 2005 6 4 354-356 16277887
31. Nieto Y Santisteban M Aramendia JM Fernandez-Hidalgo O Garcia-Manero M Lopez G Docetaxel administered during pregnancy for inflammatory breast carcinoma Clin Breast Cancer 2006 6 6 533-534 16595038
32. Andreadis C Charalampidou M Diamantopoulos N Chouchos N Mouratidou D Combined chemotherapy and radiotherapy during conception and first two trimesters of gestation in a woman with metastatic breast cancer Gynecol Oncol 2004 95 1 252-255 10.1016/j.ygyno.2004.06.037 15385141
33. Zemlickis D Lishner M Degendorfer P Panzarella T Sutcliffe SB Koren G Fetal outcome after in utero exposure to cancer chemotherapy Arch Intern Med 1992 152 3 577-576 10.1001/archinte.152.3.573 1546920
34. Byrne J Long-term genetic and reproductive effects of ionizing radiation and chemotherapeutic agents on cancer patients and their offspring Teratology 1999 59 4 210-215 10.1002/ (SICI)1096-9926(199904)59:4<210::AID-TERA4>3.0.CO;2-X 10331521
35. Ibrahim EM Ezzat AA Baloush A Hussain ZH Mohammed GH Pregnancy-associated breast cancer: A case-control study in a young population with a high-fertility rate Med Oncol 2000 17 4 293-300 11114708
36. Tomich PL Helgeson VS Is finding something good in the bad always good? Benefit finding among women with breast cancer Health Psychol 2004 23 1 16-23 10.1037/0278-6133.23.1.16 14756599
37. Hedgecoe A 'At the point at which you can do something about it, then it becomes more relevant': Informed consent in the pharmacogenetic clinic Soc Sci Med 2005 61 6 1201-1210 10.1016/j.socscimed.2005.01.021 15970231
38. Henrich J McElreath R Barr A Ensminger J Barrett C Bolyanatz A Cardenas JC Gurven M Gwako E Henrich N Lesorogol C Marlowe F Tracer D Ziker J Costly punishment across human societies Science 2006 312 5781 1767-1770 10.1126/science.1127333 16794075
39. Barthelmes L Davidson LA Gaffney C Gateley CA Pregnancy and breast cancer Bmj 2005 330 7504 1375-1378 558293 15947401 10.1136/ bmj.330.7504.1375
40. Pautier P Lhomme C Morice P Cancer and pregnancy: The medical oncologist's point of view J Gynecol Obstet Biol Reprod (Paris) 2004 33 1 Suppl S23-8 14968014
41. Mathieu E Merviel P Antoine JM Uzan S Cancer and Pregnancy: The point of view of the obstetrician Bull Cancer 2002 89 9 758-764 12368127
42. O'Donnell JL Smyth D Frampton C Prioritizing health-care funding Intern Med J 2005 35 7 409-412 10.1111/j.1445-5994.2005.00839.x 15958111